Document is current
Any future updates will be listed below
-
Authors
Yoshida, Shohei
Imai, Noboru
Keicho, Masato
Kamimura, Jun
Moriya, Asami
Yagi, Nobuyasu
Suzuki, Rieko
Konishi, Takashi
Serizawa, Masahiro
- License Information
-
More Information
Article History
Received: 9 February 2025
Accepted: 4 March 2025
First Online: 11 March 2025
Declarations
:
: This study was approved by Ethics Committee of Japanese Red Cross Society Shizuoka Hospital (approval number: 2018-21). Patients were informed about this observational study via the questionnaire of the headache outpatient clinic, and they could opt out of this study. The need for informed consent was waived by Japanese Red Cross Society Shizuoka hospital in accordance with national regulations (Ethical Guidelines for Medical and Biological Research Involving Human Subjects). All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable for that section.
: Noboru Imai reports being an advisor for Sawai and received speaker fees from Daiichi Sankyo, Eli Lilly, Otsuka, and Amgen; however, these companies had no relation to the study.
